Latest Whitepapers

Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.

This article presents current techniques in oligonucleotide production and characterization, highlighting recent advancements that enhance the efficiency of these methods

This article examines how analytical scientists can enhance their data sharing and reporting practices, leading to improvements in data integrity and an easier route to compliance within a regulated good manufacturing practice (GMP) environment.

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.

This whitepaper explores the key steps in the antibody development process and highlights how partnership with an expert manufacturing service provider can help to simplify and expedite your workflow.

In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.

This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.

These advances owe much to increased raw sequencing power and ever-more ingenious techniques for sampling genomic data, but these advances would be for naught if we weren’t able to process and analyze the data torrent that pours from these sequencing projects.

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.